… biomarkers in blood for the diagnosis of Alzheimer's disease. … proteomic technologies to
carry out research into biomarkers… plasma and serum proteome, revealing potential biomarkers, …

… of Alzheimer’s disease (AD) are intensively sought. However, no plasma markers are well …
Our group has identified and validated various blood-based proteomic biomarkers relating to …

… of knowledge on plasma biomarkers for MCI and AD, including unbiased proteomics and
very … The data are based on 32 proteins identified in plasma proteomics studies (see Table 1). …

… In summary, using a 2-DGE proteomics based approach in Alzheimer's disease plasma we
… between Alzheimer's disease cases, normal controls and other neurodegenerative diseases. …

… In one of the broadest multiplex proteomics studies of dementia conducted to date, we
identified a series of significant alterations across plasma and CSF, implicating multiple proteins …

The objective of this study was to search for biological markers associated with Alzheimer's
disease (AD). Plasma specimens obtained from ten pathologically diagnosed AD patients …

… of 107 plasma analytes; we found a plasma proteomic signature of the early clinical stages
of AD that offered a degree of diagnostic accuracy close to the established CSF biomarkers. …

… Herein, we proposed an unbiased proteomics analysis of circulating plasma exosomes
in … biomarkers. The study aimed to explore the proteomic profiling of circulating plasma …

… Plasma proteomics is a powerful tool to evaluate novel candidate biomarkers for diagnosis
and treatment of AD by measuring changes in global protein levels and monitoring specific …

… proteomic analyses of plasma collected from AD patients and cognitively normal subjects.
In addition, proteomic … Therefore, our human plasma proteomic results suggest that levels of …